Wegovy pill expands weight loss options in the USJanuary 8, 2026 Wegovy’s new pill form delivers proven weight loss results, offering adults an easier, needle-free option for long-term obesity management across the US.
Novo Nordisk cuts retail price of diabetes drug OzempicAugust 18, 2025 Uninsured Americans can now access Ozempic for $499 monthly as Novo Nordisk rolls out a direct-to-consumer model through telehealth providers.
Novo Nordisk slashes sales forecast and profits amid US drug competitionJuly 29, 2025 Novo Nordisk shares dropped 20% after cutting full-year guidance and naming a new CEO, citing U.S. market weakness for Wegovy and Ozempic.
